This inventor holds 1 USPTO granted patent. Top assignee: Edna Mcconnell Clark Foundation. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: The Innovations of Norman Colbry
Introduction
Norman Colbry is a notable inventor based in Gregory, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of schistosomiasis. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Colbry holds a patent for "Phenylpiperazines which are useful in the treatment of schistosomiasis." This patent describes a compound of the formula ##STR1##, where A is ##STR2##, n is 1, 2, or 3, and R is phenyl, which may be optionally substituted with various radicals. These include halogen, alkyl, phenyl, cyano, hydroxy, alkoxy, mercapto, sulfinyl, sulfonyl, amino, nitro, trifluoromethyl, and/or naphthyl radicals. The compound can also include a furan, thiophene, pyridine, benzofuran, dibenzothiophene, or thianthrene radical, or a pharmacologically acceptable salt thereof, for treating schistosomiasis.
Career Highlights
Colbry is associated with the Edna McConnell Clark Foundation, where he has been able to apply his expertise in pharmaceutical innovation. His work has been instrumental in advancing treatments for diseases that affect many individuals worldwide.
Collaborations
Some of his notable coworkers include Leslie M. Werbel and William Turner. Their collaborative efforts have contributed to the success of the projects they have undertaken together.
Conclusion
Norman Colbry's contributions to the field of pharmaceuticals, particularly through his patent for treating schistosomiasis, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment options.